5-Ethyl-3-methyl-5-phenylimidazolidine-2,4-dione
98%
- Product Code: 73988
CAS:
50-12-4
| Molecular Weight: | 218.25 g./mol | Molecular Formula: | C₁₂H₁₄N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00022407 | |
| Melting Point: | 135-138 °C (lit.) | Boiling Point: | |
| Density: | Storage Condition: | 2-8°C, dry |
Product Description:
This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a significant role in the development of anticonvulsant and antiepileptic drugs, contributing to the structural framework of compounds that help manage neurological disorders. Additionally, it is employed in organic synthesis for creating complex molecules with potential therapeutic applications, particularly in the field of central nervous system (CNS) disorders. Its unique structure allows it to act as a building block for designing drugs with enhanced efficacy and specificity.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white powder or crystals |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿4,990.00 |
+
-
|
| 0.050 | 10-20 days | ฿12,490.00 |
+
-
|
| 0.250 | 10-20 days | ฿46,000.00 |
+
-
|
5-Ethyl-3-methyl-5-phenylimidazolidine-2,4-dione
This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a significant role in the development of anticonvulsant and antiepileptic drugs, contributing to the structural framework of compounds that help manage neurological disorders. Additionally, it is employed in organic synthesis for creating complex molecules with potential therapeutic applications, particularly in the field of central nervous system (CNS) disorders. Its unique structure allows it to act as a building block for designing drugs with enhanced efficacy and specificity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :